Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Every Detail Matters in Hospital Seismic Retrofit

CONSTRUCTION: Difficulties Abound in Medical EnvironmentHospital earthquake planning has kept firms in San Diego like Degenkolb Engineers busy in recent years, the result of seismic retrofit deadlines drawing nearer.

Salk Partners with Indiviumed

The Salk Institute in San Diego has entered into a multi-year partnership with the cancer research company Indivumed, with the goal of turning research into medical applications.

Illumina to Open Up Market With More Affordable Sequencing

For Illumina, a fairly big announcement recently stemmed from a relatively compact box.

Tease photo

Luna DNA Seeks to Blaze New Trail to Data

BIOTECH: Co. to Use Blockchain, Cryptocurrency to Build Database

Dawn Barry recently came on board as president of the startup led by former Illumina executives like herself.

Tease photo

UC San Diego Health, Eisenhower Health Deal Expands Cancer Services

The agreement will expand cancer clinical trials and treatment options in the Coachella Valley.

Edico Brings Its Speed, Capacity to the Clinic

BIOTECH: Platform Interprets Genetic Data for Targeted Cures

The falling cost of sequencing genomes will generate a data tsunami. Edico Genome stands to make sense of much of it.

Tease photo

UnitedHealthcare Taps DexCom for Diabetes Management

Dexcom’s technology consists of a sensor that reads glucose levels just beneath the skin.

ERs Try Senior Focus For Proactive Medicine

HEALTH: Aim Is to Prevent Likely Problems, Cut Costs

Amid an aging population, San Diego hospitals have developed senior-focused emergency department services to improve care, with an eye toward their bottom lines.

Tease photo

Armed With $100M, Former Receptos Executives Launch New Biotech

In 2015, San Diego’s Receptos sold to Celgene for $7.2 billion. Rather than take it easy or go their separate ways, two Receptos’ executives immediately talked of getting the band back together.

Tease photo

DexCom Reports Big Increase in Q4 Revenue

The glucose monitoring company's unaudited revenue was $218 million during quarter ending Dec. 31.

Celgene to Buy Impact Biomedicines in $7B Deal

Impact Biomedicines was formed around reviving fedratinib, a drug intended to treat a bone marrow disorder and blood cancer.

Arcturus Therapeutics, CureVac Announce Collaboration

The companies' first joint therapy will target a genetic disease marked by ammonia accumulating in the blood.

Illumina, KingMed Partner to Develop Sequencing Technology for China

Illumina called the collaboration a “significant step” toward China Food and Drug Administration review and approval.

Look Ahead: Illumina Aims to Be ‘More Clinical, More Global, and More Digital’

After dominating the research market, genomics giant Illumina set its sights on clinics.

Tease photo

Look Ahead: NuVasive Set to Expand Its Footprint, Increase Its Staff

NuVasive is poised to keep expanding into 2018, from its balance sheet to its headquarters.

Tease photo